Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes Study
Our results indicate that apoC-I truncation may contribute to changes in glucose levels, IR, and risk of diabetes.
Authors
- Dawn C. Schwenke (ORCID: https://orcid.org/0000-0003-0920-8441)
- Yueming Hu (ORCID: https://orcid.org/0000-0001-8287-5502)
- Alain G. Bertoni (ORCID: https://orcid.org/0000-0002-7503-6273)
- Peter D. Reaven (ORCID: https://orcid.org/0000-0001-8923-6690)
- Dobrin Nedelkov
- Juraj Koska (ORCID: https://orcid.org/0000-0002-6671-6250)
- Dean Billheimer
- Matthew Jay Budoff (ORCID: https://orcid.org/0000-0002-9616-1946)
- Robyn L. McClelland
- Jeremy D. Furtado (ORCID: https://orcid.org/0000-0002-5258-1869)
Institutions
- Biogen (United States) (US)
- Harvard University (US)
- University of Arizona (US)
- University of California, Los Angeles (US)
- University of Washington (US)
- Phoenix VA Health Care System (US)
- Wake Forest University (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2024-10-25
- DOI
- https://doi.org/10.2337/dc24-1462
- Citations
- 3
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Center for Advancing Translational Sciences